See the factory by live video walkthrough
Book an on-site factory visit in Guangzhou
Dark circle eye creams are among the most requested products in the private label skincare market, but turning a concept into a market-ready product demands more than a great formula. Buyers must align ingredient…
Dark circle eye creams are among the most requested products in the private label skincare market, but turning a concept into a market-ready product demands more than a great formula. Buyers must align ingredient choices with substantiated claims, navigate regional regulations, and secure reliable documentation from manufacturers. This guide breaks down the formulation strategies, claim requirements, and practical steps to launch a compliant, effective eye cream that stands up to scrutiny.
Dark circles often fall into two categories, and the formulation should address the root cause:
Many consumers present with a mixed type. A well-rounded eye cream often combines brightening, circulation-boosting, and hydrating ingredients for visible improvement. Defining the primary mechanism early helps you select the right actives and guide claim language.
The performance of a private label eye cream hinges on the active ingredient system. Below is a comparison of commonly used ingredients and the kind of claims each can support with proper testing.
| Active Ingredient | Mechanism | Typical Use Level | Claims Supported (when substantiated) | Evidence Required |
|---|---|---|---|---|
| Vitamin C (Ascorbic Acid, 3-O-Ethyl Ascorbic Acid) | Antioxidant, tyrosinase inhibition | 0.5–15% | Brightening, reduces appearance of dark circles, evens skin tone | Stability testing, clinical or instrumental skin brightness measurement |
| Caffeine | Vasoconstriction, microcirculation boost | 1–3% | Reduces puffiness, visibly diminishes under-eye bags and dark circles | Instrumental blood flow measurement, consumer perception studies |
| Niacinamide | Anti-inflammatory, melanosome transfer inhibition | 2–5% | Brightens, improves barrier function, reduces pigmentation | Multiple in-vivo trials; standard cosmetic testing for pigmentation |
| Peptides (Palmitoyl Tetrapeptide-7, Acetyl Hexapeptide-8) | Collagen stimulation, skin firmness | 1–10% of peptide solution | Firming, smoothing, reduces fine lines, supports dark circle improvement | Elasticity/firmness instrumental measures, wrinkle depth analysis |
| Retinol / Retinyl Esters | Cell turnover, collagen synthesis | 0.01–0.3% (retinol) | Anti-aging, reduces fine lines, may improve skin thickness under eyes | Irritation patch test, stability, clinical grading of wrinkles |
| Hyaluronic Acid & Humectants | Hydration, plumping | 0.1–1% (HA) | Intense hydration, smoother under-eye texture | Corneometer hydration measurements |
To build a strong formula, working with a manufacturer that offers pre-formulated bases or custom development is key. Ask for an active ingredient dossier that includes supplier CoAs, formulation compatibility data, and recommended pH/stability ranges.
In most markets, claims like “reduces dark circles,” “clinically proven,” or “visible results in 4 weeks” require supporting evidence. The level of proof depends on the claim’s strength and the regulatory jurisdiction.
When sourcing a private label eye cream, request the manufacturer’s claim support package: a collection of existing test results that can be licensed or referenced. If you are developing a unique formula, budget 12–24 weeks for custom clinical testing. Always confirm that the manufacturer can provide the final product’s batch records, ingredient lists, and a product information file (PIF) for EU-bound products.
Eye creams are cosmetics in most regions, but careful language is needed to avoid drug classification.
Always review your label copy with a regulatory consultant if you plan to use strong before/after or percentage improvement claims. The manufacturer should supply a compliant INCI list and any necessary safety data sheets.
When vetting a private label partner for an eye cream, the following questions will help you filter serious, capable suppliers:
Securing clear answers upfront saves time and prevents last-minute reformulations.
Using an existing base formula, you can go to market in 8–12 weeks after label design and fill. Custom formulation and clinical testing may extend the timeline to 20–28 weeks.
Yes, if you have a well-designed clinical study on the final formulation. Many brands use “clinically tested” when the study is limited in scope. Consult local advertising standards; never fabricate test data.
It varies by manufacturer, but industry norms range from 1,000–5,000 units per SKU. Some labs offer lower MOQs for a stock formula with simple label customization.
Yes. An ophthalmological irritation test (e.g., HET-CAM, BCOP, or a human repeated insult patch test with ocular assessment) is strongly recommended to confirm safety around the eyes.
Focus on a unique active complex, innovative packaging (cooling metal tip, airless pump), or a compelling evidence-backed story. Transparent sharing of test summaries can build consumer trust.
Ready to launch a substantiated, high-performance eye cream? Our team can guide you from concept to compliant finished product. Request a Quote today and let’s discuss your target market, desired claims, and timeline.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.
